Cargando…
Timelines of translational science: From technology initiation to FDA approval
While timelines for clinical development have been extensively studied, there is little data on the broader path from initiation of research on novel drug targets, to approval of drugs based on this research. We examined timelines of translational science for 138 drugs and biologicals approved by th...
Autores principales: | McNamee, Laura M., Walsh, Michael Jay, Ledley, Fred D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421779/ https://www.ncbi.nlm.nih.gov/pubmed/28481922 http://dx.doi.org/10.1371/journal.pone.0177371 |
Ejemplares similares
-
Modeling timelines for translational science in cancer; the impact of technological maturation
por: McNamee, Laura M., et al.
Publicado: (2017) -
Translational Science by Public Biotechnology Companies in the IPO“Class of 2000”: The Impact of Technological Maturity
por: McNamee, Laura, et al.
Publicado: (2013) -
Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022) -
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
por: Beierlein, Jennifer M., et al.
Publicado: (2017) -
Contribution of NIH funding to new drug approvals 2010–2016
por: Galkina Cleary, Ekaterina, et al.
Publicado: (2018)